Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCairo University
About this trial
This study aims to compare the duration of analgesia (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine with hyperbaric bupivacaine to patients undergoing knee orthopedic surgery.
Eligibility criteria
Qualifiers
Age from 18 to 65 years.
American Society of Anesthesiologists (ASA) physical status I-II.
Male patients scheduled for knee orthopedic surgery.
Disqualifiers
Patients with psychiatric disorders.
History of drug addiction.
Contraindication for regional anesthesia.
History of hypersensitivity to the study drugs.
Trial design
Treatments tested in this trial
- Dexmedetomidine 4 μg
- Dexmedetomidine 8 μg
- Dexmedetomidine 12 μg
Treatment groups
120 Participants
are divided into 3 treatment groupsLocations
1Cairo University12613, Cairo Egypt
Sponsors and collaborators
Cairo University
Lead sponsor
Source ClinicalTrials.gov